Abstract
Despite nearly a century of awareness of the efficacy of various kinds of endocrine therapies in the management of patients with metastatic breast cancer, many facets of the mechanisms whereby hormones influence the growth of neoplastic tissue remain incompletely understood. Since the initial discovery in 1971 by Jensen et al1 that some breast cancers contain estrogen receptors, substantial progress has been made in understanding the critical role of these hormone binding sites in metabolism and neoplastic growth and in characterizing how these receptors are capable of interacting with nuclear material and activating transcription of specific genes.2,3 Many studies have shown that there is an excellent correlation between the presence of estrogen receptor activity and hormone triggered growth responses in breast tumors.4 Anti-estrogen or high dose estrogen mediated cytotoxicity of breast cancer also requires the presence of an estrogen receptor. Specifically, if the tumor lacks estrogen receptor the chance of seeing an objective response to endocrine therapy is only 5 percent or less. On the other hand, if the tumor contains receptor then the likelihood of a response to endocrine therapy is approximately 50 to 60 percent. Thus, there is a subset of patients who, despite the presence of estrogen binding activity, fail to show a response to endocrine therapy. The present article summarizes current information on cell culture models for this disease entity.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
E. V. Jensen, G. E. Black, S. Smith, K. Kyser, E. R. DeSombre, Estrogen receptors and breast cancer response to adrenalectomy. J. Natl. Cancer Inst. 34: 55 (1971).
W. W. Grody, S. T. Schrader, B. W. O’Malley, Activation, transformation, and subunit structure of steroid hormone receptors. Endocr. Review 3: 141 (1982).
K. R. Yamamoto, U. Gehring, M. R. Stampfer, Genetic approaches to steroid hormone actions. Recent Prog. Horm. Res. 32: 3 (1972).
W. L. McGuire, P. P. Carbone, M. E. Sears, G. E. Escher, Estrogen receptors in human breast cancer: an overview. In: McGuire WL, Carbone PP, Volmer EP (eds) Estrogen Receptors in Human Breast Cancer. Raven Press, Inc. New York (1975).
K. R. Yamamoto, M. R. Stampfer, G. M. Tompkins, Receptors from glucocorticoid-sensitive lymphoma cells and two classes of insensitive clones: physical and DNA-binding properties. Proc. Natl. Acad. Sci. 71: 3901 (1974).
S. Bourgeois, R. Newby, Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell 11: 423 (1977).
J. M. Harmon, E.B. Thompson, Isolation and characterization of Dexamethasone-resistant mutants from human lymphoid cell line CEM-C7. Mol. Cell Biol. 81: 512 (1981).
J. E. Griffin, J. D. Wilson, The syndrome of androgen resistance. New Engl. J. Med. 302: 198 (1980).
H. D. Soule, J. Vazquez, A. Lury, S. Albert, M. Brennan, A human breast cancer line from a pleural effusion derived from a breast carcinoma. J. Natl. Cancer Inst. 51: 1409 (1973).
M. E. Lippman, G. Bolan, K. Huff, The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res. 36: 4595 (1976).
M. E. Lippman, Definition of hormones and growth factors required for optimal proliferation and expression of phenotypic responses to human breast cells. In: Barnes D (ed) Methods in Molecular and Cell Biology. Alan R. Liss, Inc. New York (in press) (1983).
A. Kasid, D. Bronzert, M. E. Lippman, Estradiol responsive human breast cancer cells in culture. In: Aurrichio E (ed) Gonad Steroid Receptors. Field Enterprises, Chicago (in press).
M. E. Lippman, G. Bolan, Oestrogen responsive human breast cancer in long-term tissue culture. Nature 256: 592 (1975).
S. C. Aitken, M. E. Lippman, Hormonal regulation of net DNA synthesis in MCF-7 human breast cancer cells in tissue culture. Cancer Res. 42: 1727 (1982).
R. Weichselbaum, S. Hellman, A. Piro, J. Nore, J. Little, Proliferative kinetics of a human breast cancer line in vitro following treatment with 173-estradiol and 1-ß-Darabinofuranosulcytosine. Cancer Res. 38: 2339 (1978).
M. J. Page, J. K. Field, N. P. Everett, C. D. Green, Serum regulation of the estrogen responsiveness of the human breast cancer cell line MCF-7. 43: 1244 (1983).
B. S. Katzenellenbogen, M. J. Norman, R. L. Eckert, S. W. Peitz, W. F. Mangel, Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxy-tamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res 44: 112 (1984).
D. Chalbos, F. Vignon, I. Kaydar, H. Rochefort, Estrogens in a human breast cancer cell line (T47D). J. Clin. Endo. Metab. 55: 276 (1982).
W. Yu, B. S. Leung, Y. L. Gao, Effects of 173-estradiol or progesterone receptors and the uptake of thymidine in human breast cancer cell line CAMA-1. Cancer Res. 41: 5004 (1981).
C. Natoli, S. Gigliola, V. Natoli, A. Secca, S. Iacobelli, Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line. Breast Cancer Res. Treat. 3: 23 (1983).
D. A. Bronzert, M. E. Monaco, L. Pinkus, S. Aitken, M. E. Lippman, Purification and properties of estrogen responsive cytoplasmic thymidine kinase from human breast cancer. Cancer Res. 41: 604 (1981).
S. C. Aitken, M. E. Lippman, Effect of estrogens and anti-estrogens on growth regulatory enzymes in human breast cancer cells in tissue culture. Cancer Res. (in press).
K. Cowan, R. Levine, S. Aitken, M. Goldsmith, E. Douglass, N. Clendeninn, A. Nienhuis, M. Lippman, Dihydrofolate reductase gene amplification and possible rearrangement in estrogen-responsive methotrexate-resistant human breast cancer cells. J. Biol. Chem. 257: 15079 (1982).
R. E. Burke, S. C. Harris, W. L. McGuire, Lactate dehydrogenase in estrogen-responsive human breast cancer cells. Cancer Res. 38: 2773 (1978).
B. Westley, H. Rochefort, A secreted glycoprotein induced by estrogen in human breast cancer cell lines. Cell 20: 353 (1980).
D. P. Edwards, D. J. Adams, W. L. McGuire, Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7). Breast Cancer Res. Treat. 1: 209 (1981).
P. Maisiakowski, R. Breathnach, J. Block, F. Gannon, A. Krast, P. Chambon, Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res. 24: 7895 (1982).
K. Siebert, S. Shafie, T. Triche, J. Whang-Peng, S. O’Brien, J. Toney, K. Huff, M. Lipman, Clonal variation of MCF-7 breast cancer cells in vitro and in athymic nude mice. Cancer Res. 43: 2223 (1983).
D. A. Bronzert, G. L. Greene, M. E. Lippman, Selection and characterization of a breast cancer cell line resistant to the anti-estrogen LY 117018. Endocrinology (submitted).
K. B. Horwitz, W. L. McGuire, Estrogen control of progesterone receptor in human breast cancer. J. Biol. Chem. 253: 2223 (1978).
S. M. Scholl, K. K. Huff, M. E. Lippman, Anti-estrogenic effects of LY 117018 in MCF-7 cells. Endocrinology 113: 611 (1983).
E. K. Watts, L. C. Murphy, R. L. Sutherland, Microsomal binding sites for non-steroidal anti-estrogens in MCF-7 human mammary carcinoma cells. J. Biol. Chem. 259: 4223 (1984).
L. J. Black, R. L. Goode, Evidence for biological action of the antiestrogens LY 117018 and tamoxifen by different mechanisms. 109: 987 (1981).
R. M. Hillman, W. B. Butler, Sensitivity of clones of the human breast cancer cell line MCF-7 to the anti-estrogens tamoxifen and 4-0H tamoxifen. Amer. Assoc. Cancer Res. 25: 205 (abstract) (1984).
W. B. Butler, W. H. Kelsey, N. Goran, Effect of serum and insulin on the sensitivity of the human breast cancer cell line MCF-7 to estrogen and anti-estrogens 41: 82 (1981).
L. J. Brandes, M. W. Hermonat, Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol. Cancer Res. 43: 2831 (1983).
D. Bronzert, R. B. Hochberg, M. E. Lippman, Specific cytotoxicity of 16-[125I]iodoestradiol for estrogen receptor-containing breast cancer cells. Endocrinology 110: 2177 (1982).
D. A. Bronzert, T. J. Triche, P. Gleason, M. E. Lippman, Isolation and characterization of an estrogen inhibited variant from the MCF-7 breast cancer cell line. Cancer Res. 44: 3942 (1984).
R. Jakesz, C. A. Smith, S. Aitken, K. Huff, W. Schuette, S. Shackney, M. Lippman, Influence of cell proliferation and cell cycle phase on expression of estrogen receptor in MCF-7 cells. Cancer Res. 44: 619 (1984).
N. Brunner, M. Spang-Thomsen, L. Vindelov, A. Nielson, Effect of l70,-estradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice. Br. J. Cancer 47: 641 (1983).
N. Brunner, M. Spant-Thomsen, L. Vindelow, A. Nielson, S. Engelholm, Svenstrump, Dose-dependent effect of 171-estradiol determined by growth curves and flow cytometric DNA analysis of a human breast carcinoma (T61) grown in nude mice. Exp. Cell Biol. (in press) (1984).
H. Nawata, D. Bronzert, M.E. Lippman, Isolation and characterization of a tamoxifen-resistant cell line derived from MCF-7 human breast cancer cells. J. Biol. Chem. 256: 5016 (1981).
H. Nawata, M. J. Chong, D. Bronzert, M.E. Lippman, Estradiolindependent growth of a subline of MCF-7 human breast cancer cells in culture. J. Biol. Chem. 256: 6895 (1981).
M. A. Miller, M. E. Lippman, B. Katzenellenbogen. Anti-estrogen binding in anti-estrogen growth resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells. Cancer Res. 44: 5038 (1984).
F. Vignon, M. E. Lippman, H. Nawata, D. Derocq and H. Rochefort, Induction of two estrogen-responsive proteins by anti-estrogens in R27, a Tamoxifen-resistant clone of MCF-7 cells. Cancer Res. 44: 2084 (1984).
L. J. Black, R. L. Goode, Uterine bioassay of tamoxifen, trioxifene, and a new estrogen antagonist (LY 117018) in rats and mice. Life Sci. 26: 1453 (1980).
R. J. Kaufman, P. C. Brown, R. T. Schimke, Amplified dihydrofo-late stimulate cell proliferation and induce secretory proteins reductase genes in unstably methotrexate-resistant cells are associated with double minute chromosomes. Proc. Natl. Acad. Sci. USA 76: 5669 (1979).
K. B. Horwitz, D. T. Zava, A. K. Thilager, E. M. Jensen, W. L. McGuire, Steroid receptor analyses of nine human breast cancer cell lines. Cancer Res. 38: 2434 (1978).
W. W. Leavitt, T. J. Chen, T. C. Allen, Regulation of progesterone receptor formation by estrogen action. Ann NY Acad Sci 286: 210 (1977).
B. Westley, F. May, T. Brown, A. Krust, P. Chambon, M. Lippman and H. Rochefort, Effects of anti-estrogens on the estrogen regulated pS2 RNA, 52K and 160K proteins in MCF-7 cells and two tamoxifen resistant sublines. J. Biol. Chem. 259: 10030 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Bronzert, D.A., Davidson, N., Lippman, M. (1986). Estrogen and Antiestrogen Resistance in Human Breast Cancer Cell Lines. In: Chrousos, G.P., Loriaux, D.L., Lipsett, M.B. (eds) Steroid Hormone Resistance. Advances in Experimental Medicine and Biology, vol 196. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-5101-6_22
Download citation
DOI: https://doi.org/10.1007/978-1-4684-5101-6_22
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-5103-0
Online ISBN: 978-1-4684-5101-6
eBook Packages: Springer Book Archive